Definitive Contract 75A50124C00010

Award Date 4/11/24
Potential Completion Date 4/30/28
Potential Value $30M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Richmond, VA 23219, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded Kaleo, Inc. a $4.5 million definitive contract to purchase epinephrine auto-injectors for the Strategic National Stockpile. The firm fixed price contract runs from January 5 to 15, 2021 and supports COVID-19 national interest activities. Kaleo will deliver epinephrine auto-injectors to a location in Atlanta, Georgia to bolster the stockpile in response to the coronavirus pandemic....
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $220,246,768 Definitive Contract to Aktivax, Inc. to support late-stage clinical development, regulatory approval, and procurement of 2-PAM autoinjectors as a drug-device combination product to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations. This acquisition, which is not set-aside, will allow ASPR's Biomedical...
This federal contract award to Kaleo, Inc. for $452,310.00 was issued by the Veterans Integrated Service Network 12 (VISN 12), a part of the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of NALOXONE 0.4MG/0.4ML AUTOINJECTOR,KIT, which are critical medical countermeasures used to address the opioid crisis and support emergency response efforts. Kaleo, Inc. is a pharmaceutical company that specializes in innovative auto-injector technologies for life-saving...
This is a federal contract award to Kaleo, Inc., a Richmond, VA based pharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide Naloxone Injector Kits. The contract is a Delivery Order under the VA's Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs contract, with a Firm Fixed Price of $198,000.00. Kaleo has held multiple federal contracts to provide medical countermeasures and pharmaceuticals, including awards from the...
This federal contract award, valued at $2,086.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4,563,189,968 units of epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The contract is a delivery order and is priced on a firm-fixed-price basis, with a completion date of December...
This federal contract award is for the delivery of 4,564,375 units of the epinephrine 0.3 mg auto-injector medical device, valued at $1,378.08. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This single-award IDC...
This federal contract award is for the supply of epinephrine 0.3 mg auto-injectors to the U.S. government. The contract, valued at $4,485.90, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of 4,565,786,703 units of Epinephrine 0.3 mg auto-injector (2-pack) to the agency. The $1,495.30 firm-fixed price contract has a completion date of September 16, 2024 and does not utilize any set-aside designations. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides a wide range of medical supplies and medications to various...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The contract, valued at $2,100.61, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued...
This federal contract award is for the delivery of 4,565,069,710 units of epinephrine 0.3 mg auto-injectors over a two-year period ending on July 5, 2024. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price ceiling of $1,150.20 and was awarded without the use of any set-aside designations. Amerisourcebergen also holds a $999,999,999.00 Indefinite...

The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded Kaleo, Inc., a $30,344,948.00 cost-plus-fixed-fee contract for the development of a novel pralidoxime chloride auto-injector device. This contract supports ASPR's Biomedical Advanced Research and Development Authority (BARDA) program, which focuses on medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging infectious diseases. Kaleo, a pharmaceutical company specializing in auto-injector technologies, has established itself as a key supplier of critical medical products to various federal agencies. The contract has an ultimate completion date of April 30, 2028, and there was no set-aside designation used. This award is part of Kaleo's broader portfolio of federal contract vehicles, including Indefinite Delivery Vehicles (IDVs) with the Department of the Army and the Department of Veterans Affairs for the procurement of auto-injector devices and other pharmaceutical items.

Generated 12/22/24, 12:14 AM